Finally, it is important to note that this review is a synthesis of the existing literature and, as such, does not involve the collection or analysis of original data
There is: No evidence that Epitalon can shrink existing tumors in humans No human clinical trials testing its use in oncology No mechanistic studies confirming how Epitalon affects tumor microenvironments or immune evasion in vivo What we do have is a compelling preventive profile in animal models, especially where aging and genetic susceptibility intersect
Its the active form your body uses immediately no conversion required
Third-Party Tested Independently verified active ingredients
The compound also enhances GLUT4 expression and promotes production of palmitic acid hydroxy stearic acids (PAHSAs), an alternative lipid class exhibiting anti-diabetic and anti-inflammatory properties
Additionally, the possibility of interactions with other peptides or compounds highlights the necessity for careful consideration of patient safety and specific needs